CJC-1295 NO DAC — 5 mg

CJC-1295 NO DAC — 5 mg

CJC-1295 NO DAC is a synthetic peptide widely studied in research settings for its selective interaction with growth hormone–releasing hormone (GHRH) pathways without extended half-life modification. Researchers examine it for how it stimulates pulsatile growth hormone signaling, aligns with natural circadian secretion patterns, and influences downstream physiological markers without broadly activating other pituitary hormone systems.

Key Research Observations on CJC-1295 NO DAC

Pulsatile growth hormone stimulation
Research literature describes CJC-1295 NO DAC as a short-acting GHRH analog that promotes growth hormone release in a pulse-like manner, closely mirroring endogenous growth hormone secretion dynamics.

Minimal impact on cortisol and prolactin
Studies note CJC-1295 NO DAC’s pathway specificity, observing little to no elevation in cortisol, prolactin, or other non–growth hormone pituitary hormones in research models.

Alignment with circadian hormone rhythms
Scientific investigation explores how CJC-1295 NO DAC may synchronize with natural growth hormone pulse timing, particularly during sleep-associated secretion windows.

Interest in recovery and metabolic signaling research
Academic and preclinical research examines CJC-1295 NO DAC for its downstream effects related to tissue recovery signaling, protein synthesis pathways, and metabolic regulation under controlled experimental conditions.